Shorepath Capital Management LLC Sells 15,415 Shares of Danaher Corporation $DHR

Shorepath Capital Management LLC decreased its position in shares of Danaher Corporation (NYSE:DHR) by 46.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,798 shares of the conglomerate’s stock after selling 15,415 shares during the quarter. Danaher comprises approximately 2.9% of Shorepath Capital Management LLC’s investment portfolio, making the stock its 14th largest position. Shorepath Capital Management LLC’s holdings in Danaher were worth $3,516,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Sierra Ocean LLC raised its holdings in Danaher by 116.9% during the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 76 shares during the last quarter. Red Tortoise LLC raised its holdings in Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the 1st quarter worth approximately $31,000. Ramirez Asset Management Inc. bought a new stake in shares of Danaher in the 2nd quarter valued at $40,000. Finally, Costello Asset Management INC bought a new stake in shares of Danaher in the 1st quarter valued at $41,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $213.99 on Thursday. The firm has a market capitalization of $151.15 billion, a PE ratio of 44.12, a price-to-earnings-growth ratio of 3.32 and a beta of 0.77. The firm has a fifty day simple moving average of $203.12 and a two-hundred day simple moving average of $199.20. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion during the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.44% and a return on equity of 10.92%. Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is 26.39%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on DHR shares. JPMorgan Chase & Co. lifted their price objective on shares of Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Cowen reiterated a “buy” rating on shares of Danaher in a research note on Wednesday, October 22nd. Rothschild & Co Redburn reiterated a “neutral” rating and issued a $220.00 price objective (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Robert W. Baird set a $247.00 price objective on shares of Danaher in a research note on Wednesday, October 22nd. Finally, Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, October 25th. Eighteen research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $243.39.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.